Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 81-86 , 15 April 2010

The antibody response to oligodendrocyte specific protein in multiple sclerosis

Received 18 November 2009 ,Revised 7 February 2010 ,Accepted 9 February 2010.

References 

  1. Bajramovic JJ, Brok HPM, Ouwerling B, Jagessar SA, van Straalen L, Kondova I, et al. Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve. Eur. J. Immunol. 2008;38:1452–1464
  2. Breithaupt C, Schäfer B, Pellkofer H, Huber R, Linington C, Jacob U. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 2008;181:1255–1263
  3. Brilot F, Dale RC, Selter RC, Grummel V, Kalluri SR, Aslam M, et al. Antibodies to native MOG in children with inflammatory demyelinating disease. Ann. Neurol. 2009;66:833–842
  4. Bronstein JM, Lallone RL, Seitz RS, Ellison GW, Myers LW. A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic. Neurology. 1999;53:154–161
  5. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, et al. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell. 1999;99:649–659
  6. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, et al. B-cell depletion with rituximab in relapsing–remitting multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2008;358:676–688
  7. Kaushansky N, Zhong M-C, Kerlero de Rosbo N, Hoeftberger R, Lassmann H, Ben-Nun A. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 2006;177:7364–7376
  8. Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005;366:579–582
  9. Lassmann H, Raine CS, Antel J, Prineas JW. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 1998;86:213–217
  10. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112
  11. McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, McArdel S, et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 2009;183:4067–4076
  12. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N. Engl. J. Med. 2000;343:938–952
  13. O'Connor K, McLaughlin K, De Jager P, Chitnis T, Bettelli E, Xu C, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Advanced online publication. Nat. Med. 2007;13:211–217
  14. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007;4:e133
  15. Reindl M, Khalil M, Berger T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 2006;180:50–62
  16. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005;23:683–747
  17. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2001;2:762–764
  18. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 1998;43:465–471
  19. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235–1243
  20. Tiwari-Woodruff SK, Myers LW, Bronstein JM. Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration. J. Neurosci. Res. 2004;77:363–366
  21. Tiwari-Woodruff S, Beltran-Parrazal L, Charles A, Keck T, Vu T, Bronstein J. K+ channel KV3.1 associates with OSP/claudin-11 and regulates oligodendrocyte development. Am. J. Physiol. Cell. Physiol. 2006;291:687–698
  22. von Büdingen H-C, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 2002;99:8207–8212
  23. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 1999;46:878–886
  24. Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Brück W, et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006;103:19057–19062

PII: S0165-5728(10)00057-3

doi: 10.1016/j.jneuroim.2010.02.008

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 81-86 , 15 April 2010

Article Tools

* Image Usage & Resolution